Dose Conversion and Titration with a Novel, Once-Daily, OROS⁽R) Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain

Authors: Palangio M.; Northfelt D.W.; Portenoy R.K.; Brookoff D.; Doyle R.T.; Dornseif B.E.; Damask M.C.

Source: Journal of Pain and Symptom Management, Volume 23, Number 5, May 2002 , pp. 355-368(14)

Publisher: Elsevier

Keywords: Chronic malignant pain; chronic nonmalignant pain; dose conversion; extended-release; hydromorphone; titration

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0885-3924(02)00390-1

Affiliations: 1: Abbott Laboratories, Parsippany, NJ, USA

Publication date: 2002-05-01

• In this: publication
• By this: publisher
• In this Subject: Pathology
• By this author: Palangio M. ;  Northfelt D.W. ;  Portenoy R.K. ;  Brookoff D. ;  Doyle R.T. ;  Dornseif B.E. ;  Damask M.C.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers